UDP-galactose: -N-acetyl-glucosamine -1,4-galactosyltransferase, 4Gal-T2

   
   

A novel gene defining a novel enzyme in the UDP-D-galactose: b-N-acetyl-glucosamine -1,4-galactosyltransferase family, termed 4Gal-T2, with unique enzymatic properties is disclosed. The enzymatic activity of 4Gal-T2 is shown to be distinct from that of previously identified enzymes of this gene family. The invention discloses isolated DNA molecules and DNA constructs encoding 4Gal-T2 and derivatives thereof by way of amino acid deletion, substitution or insertion exhibiting 4Gal-T2 activity, as well as cloning and expression vectors including such DNA, cells transfected with the vectors, and recombinant methods for providing 4Gal-T2. The enzyme 4Gal-T2 and 4Gal-T2-active derivatives thereof are disclosed, in particular soluble derivatives comprising the catalytically active domain of 4Gal-T2. Further, the invention discloses methods of obtaining -1,4-galactosyl glycosylated saccharides, glycopeptides or glycoproteins by use of an enzymically active 4Gal-T2 protein or fusion protein thereof or by using cells stably transfected with a vector including DNA encoding an enzymatically active 4Gal-T2 protein as an expression system for recombinant production of such glycopeptides or glycoproteins. Also a method for the identification of DNA sequence variations in the 4Gal-T2 gene by isolating DNA from a patient, amplifying 4Gal-T2-coding exons by PCR, and detecting the presence of DNA sequence variation, are disclosed.

 
Web www.patentalert.com

< Method for reducing malodor of chondroitin

< Antisense modulation of CoREST expression

> Process for producing hydrazinomonosaccharide derivatives and use thereof

> Carbohydrate prodrugs of fluorooxindoles

~ 00193